Fred Hutchinson Cancer Research Center

Genelex Corporation, based in Seattle, WA, has been a leader in genetic testing and molecular diagnostics for over 30 years, specializing in pharmacogenetics (PGx). The company offers a comprehensive pharmacogenetic test that analyzes how a patient's genes affect their response to medications, aiming to enhance personalized medicine. As a CLIA-certified laboratory, Genelex emphasizes adherence to best practices, providing accurate results supported by clinical validity and ongoing customer support. Their innovative approach combines advanced analytics, state-of-the-art laboratory facilities, and expert staff to assist healthcare providers in optimizing medication management and minimizing adverse drug events. Generated from the website

Founded in 1987, Gilead Sciences is one of the leaders in the discovery and development of a new class of human therapeutics based on nucleotides, the building blocks of DNA and RNA in the United States. The company discovers, develops and commercializes medications to advance the care of patients suffering from life-threatening diseases. Headquartered in Foster City, Calif., it serves North America, Europe and Australia and employs a staff of more than 3,400 individuals. Gilead Sciences areas of focus include antivirals, such as HIV/AIDS and chronic hepatitis, as well as cardiovascular conditions, including pulmonary arterial hypertension and resistant hypertension. The company also conducts studies on various respiratory diseases, such as influenza and cystic fibrosis.